Skip to main content

Table 3 The Dose received by 98% of prostate volume (D98%) at the end of the delivered treatment is reported in column 2, DVHs cut-off points V70Gy for bladder in column 3, and V40Gy and V70Gy for rectum in columns 4 and 5 respectively; the first value shown is for the planned treatment and in brackets for the delivered one

From: Dose tracking assessment for image-guided radiotherapy of the prostate bed and the impact on clinical workflow

Patient

PTV, D98%

Bladder, V70Gy

Rectum, V40Gy

Rectum, V70Gy

D98% (Gy)

Vol (%)

Vol (%)

Vol (%)

1

69.5 (70.2)

23% (25%)

30% (30%)

5% (4%)

2

71.5 (72.0)

38% (32%)

22% (22%)

2% (2.0%)

3a

69.0 (67.4)

26% (26%)

51% (49%)

16% (10%)

4

71.5 (66.0)

28% (36%)

26% (26%)

3% (3%)

5

71.8 (67.0)

15% (28%)

32% (35%)

0% (0.0%)

6

71.6 (72.5)

25% (3%)

27% (24%)

1% (1%)

7

70.6 (69.8)

30% (30%)

21% (20%)

3% (2%)

8

70.0 (71.5)

23% (29%)

26% (25%)

3% (%)

9

69.8 (70.0)

10% (12%)

13% (32%)

0% (0%)

10

70.7 (69.5)

25% (25%)

12% (11%)

1% (2%)

11

69.5 (68.5)

24% (37%)

20% (32%)

3% (4%)

12

70.2 (69.5)

20% (18%)

32% (32%)

0% (0%)

13

70.0 (69.2)

15% (10%)

55% (55%)

3% (1%)

14

70.5 (69.7)

23% (29%)

48% (40%)

7% (5%)

  1. a For Patient 3, V50Gy =47% (79%) planned and delivered respectively
  2. Values out of the expected values (2.5% of difference for D98%, out of the limits for OARs) are reported in bold